SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GRANULES INDIA

BSE: 532482 20 Aug 2025
Healthcare
₹ 456.85
Granules India Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GRANULES INDIA - Share Price & Details

Market Cap
₹11,142
High /Low
725.0 / 412.0
Stock P/E
23.4
Book Value
₹153.0
Dividend Yield
0.33
ROCE
15.1
ROE
₹13.9
Face Value
1.0
PEG Ratio
4.73
EVEBITDA
₹12.5
Debt
1,455
CMP / FCF
48.8
Debt to equity
₹0.39
NP Ann
502
High price all time
725.0
Piotroski score
₹7.0
Graham Number
261.0
No. Eq. Shares
24.3
Net CF
₹85.0
Net profit
480
Price to book value
2.99
Interest Coverage
₹7.18
Low price all time
2.53
Industry PE
33.5
Reserves
₹3,691
Free Cash Flow
₹297

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
GRANULES INDIA LTD.8233.6694.858102.082.8611,14223.4
Metropolis Healthcare Limited3264.12355.823236.326.841110473.0
Vijaya Diagnostic Centre Limit1822.68383.891748.453.731083271.8

Peer Comparison Chart


About GRANULES INDIA

Granules India Ltd., with Security Code 532482, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Granules India Q1 Results: Revenue rises 3% on North America push; margin narrows

(12 Aug 2025)
Granules India Ltd. reported its results for the June quarter on Tuesday, August 12, which were subdued on most parameters on a year-on-year...
Read more →

Paracetamol maker Granules India's quarterly profit drops on supply backlog

(12 Aug 2025)
Paracetamol maker Granules India reported a first-quarter profit fall on Tuesday, as a supply backlog hit sales.
Read more →

Granules India Q1 Results: Net profit dips 16%, revenue rises on strong sales growth in North America

(12 Aug 2025)
The research and development (R&D) expenses stood at ₹68 crore (5.6% of sales) in Q1 FY26 as compared to ₹66.5 crore (5.5%) in Q4 FY25.
Read more →

Q1 Results Highlights: Hindalco, Nykaa, Zydus Lifesciences profit rise; Karnataka Bank, MRF, others report declines

(12 Aug 2025)
Q1 Results Highlights: HAL, ONGC, Hindalco, NSDL, Apollo Hospitals, Jindal Steel, Zydus Lifesciences, Suzlon Energy, Oil India, MRF,...
Read more →

Anakapalli collector inaugurates transformed hostel in Parawada under Granules India CSR Initiative

(08 Aug 2025)
News News: Anakapalli district collector Vijaya Krishnan inaugurated the transformed BC government boys' hostel in Parawada, revamped under...
Read more →

Be Sure To Check Out Granules India Limited (NSE:GRANULES) Before It Goes Ex-Dividend

(30 Jul 2025)
Granules India Limited ( NSE:GRANULES ) stock is about to trade ex-dividend in two days. The ex-dividend date generally...
Read more →

Company Updates